cbdMD (YCBDPA.PFD) Gross-Profit-to-Asset % : 105.30% (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is cbdMD Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. cbdMD's annualized Gross Profit for the quarter that ended in Mar. 2025 was $11.84 Mil. cbdMD's average Total Assets over the quarter that ended in Mar. 2025 was $11.24 Mil. Therefore, cbdMD's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 was 105.30%.

cbdMD Gross-Profit-to-Asset % Historical Data

The historical data trend for cbdMD's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

cbdMD Gross-Profit-to-Asset % Chart

cbdMD Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

25.68

25.44

26.96

52.57

89.60

cbdMD Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															69.65	95.91	80.38	122.98	105.30

Competitive Comparison of cbdMD's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, cbdMD's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

cbdMD's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, cbdMD's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where cbdMD's Gross-Profit-to-Asset % falls into.

Save Embed

;

Save Embed

;

cbdMD Gross-Profit-to-Asset % Calculation

cbdMD's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Sep. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Sep. 2024 )	/	( (Total Assets (A: Sep. 2023 )	+	Total Assets (A: Sep. 2024 ))	/ count )
	=	11.996	/	( (16.195	+	10.581)	/ 2 )
	=	11.996	/	13.388
	=	89.60 %

cbdMD's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Mar. 2025 )	/	( (Total Assets (Q: Dec. 2024 )	+	Total Assets (Q: Mar. 2025 ))	/ count )
	=	11.836	/	( (11.543	+	10.938)	/ 2 )
	=	11.836	/	11.2405
	=	105.30 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2025) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

cbdMD Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of cbdMD's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

cbdMD Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » cbdMD Inc (AMEX:YCBDPA.PFD) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

YCBD:USA

Address

2101 Westinghouse Boulevard, Suite A, Charlotte, NC, USA, 28273

Website

https://www.cbdmd.com

cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.